Axsome Therapeutics Announces Publication of Research Showing AXS-02 Inhibits Pain in Animal Model of Complex Regional Pain Syndrome
October 04, 2016 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
Axsome Therapeutics Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain Syndrome
March 15, 2016 07:00 ET
|
Axsome Therapeutics, Inc.
Provides Patent Protection for AXS-02 into 2033Covers Uses of Oral Zoledronic Acid for Complex Regional Pain SyndromeRepresents the 19th Issued Patent Covering AXS-02 or Related Compounds NEW YORK,...